Novo Nordisk A/S Release: Transaction in Own Shares

BAGSVÆRD, DENMARK--(Marketwire - August 03, 2009) - Novo Nordisk A/S - Share repurchase programme

On 29 January 2009, Novo Nordisk initiated its share repurchase programme in accordance with the provisions of the European Commission's regulation no 2273/2003 of 22 December 2003, also referred to as the Safe Harbour rules.

Under the programme Novo Nordisk will repurchase B shares for an amount up to DKK 3.0 billion in the period from 29 January 2009 to 5 August 2009.

Since the announcement as of 27 July 2009, the following transactions have been made under the programme:

Number of Average purchase Transaction shares price value, DKK Accumulated, last announcement 9,950,382 2,778,221,354 27 July 2009 75,000 304.9250 22,869,375 28 July 2009 95,000 312.0840 29,647,980 29 July 2009 149,500 305.6500 45,694,675 30 July 2009 85,000 307.7800 26,161,300 31 July 2009 85,000 307.2900 26,119,650 Accumulated under the programme 10,439,882 2,928,714,334

With the transactions stated above, Novo Nordisk owns a total of 21,231,941 treasury shares, corresponding to 3.4% of the share capital. The total amount of shares in the company is 620,000,000 including treasury shares.

Novo Nordisk is a healthcare company and a world leader in diabetes care. In addition, Novo Nordisk has a leading position within areas such as haemostasis management, growth hormone therapy and hormone replacement therapy. Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession and society. With headquarters in Denmark, Novo Nordisk employs more than 27,900 employees in 81 countries, and markets its products in 179 countries. Novo Nordisk's B shares are listed on the stock exchanges in Copenhagen and London. Its ADRs are listed on the New York Stock Exchange under the symbol 'NVO'. For more information, visit novonordisk.com.

Company Announcement no 45 / 2009

This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.

Copyright © Hugin AS 2009. All rights reserved.